Raymond James Financial Inc. Invests $3.23 Million in CRISPR Therapeutics AG (NASDAQ:CRSP)
Raymond James Financial Inc. bought a new position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 82,095 shares of the company’s stock, valued at approximately $3,231,000. A number of other institutional investors […]
Raymond James Financial Inc. bought a new position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 82,095 shares of the company’s stock, valued at approximately $3,231,000. A number of other institutional investors […]
